Literature DB >> 23015347

Hyponatremic seizure due to huge abdominal cerebrospinal fluid pseudocsyt in a child with ventriculoperitoneal shunt: a case report.

Behcet Ilker Buyukyavuz1, Levent Duman, Tamer Karaaslan, Aysen Turedi.   

Abstract

Placement of ventriculoperitoneal(VP) shunt is a worldwide accepted procedure for treatment of hydrocephalus. This procedure have various intra-abdominal complications, of which pseudocyst formation is a rare one. Common presentations of this complication are abdominal mass, abdominal pain, intestinal obstruction, and shunt dysfunction. In this paper, we report a case of 3 year-old boy with cerebrospinal fluid (CSF) pseudocyst of the VP shunt presenting with hyponatremic seizure. To the best of our knowledge, hyponatremic seizure has not been previously reported as a presentation of abdominal CSF pseudocyst in the literature. Our case has also the largest CSF pseudocyst with respect to body surface area of the child in the literature.

Entities:  

Mesh:

Year:  2012        PMID: 23015347     DOI: 10.5137/1019-5149.JTN.3978-10.1

Source DB:  PubMed          Journal:  Turk Neurosurg        ISSN: 1019-5149            Impact factor:   1.003


  3 in total

Review 1.  Abdominal cerebrospinal fluid pseudocyst: a comparative analysis between children and adults.

Authors:  Carlos B Dabdoub; Carlos F Dabdoub; Mario Chavez; Jimmy Villarroel; Jose L Ferrufino; Adan Coimbra; Bianca M Orlandi
Journal:  Childs Nerv Syst       Date:  2014-01-29       Impact factor: 1.475

2.  Intraabdominal Pseudocyst Developed after Ventriculoperitoneal Shunt: A Case Report.

Authors:  Erdogan Ayan; Halil Ibrahim Tanriverdi; Tezcan Caliskan; Ufuk Senel; Numan Karaarslan
Journal:  J Clin Diagn Res       Date:  2015-06-01

3.  Morinda citrifolia L. (noni) and memantine attenuate periventricular tissue injury of the fourth ventricle in hydrocephalic rabbits.

Authors:  Sibel Köktürk; Süreyya Ceylan; Volkan Etus; Nezih Yasa; Savaş Ceylan
Journal:  Neural Regen Res       Date:  2013-03-25       Impact factor: 5.135

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.